Outcome of sepsis patients stratified according to platelet counts on ICU admission
| . | Very low (<50 × 109/L) . | Intermediate-low (50 × 109 to 99 × 109/L) . | Low (100 × 109 to 149 × 109/L) . | Normal (150 × 109 to 399 × 109/L) . | P . |
|---|---|---|---|---|---|
| Patients, n (%) | 61 (6.6%) | 121 (13.0%) | 167 (17.9%) | 580 (62.3%) | |
| Length of stay median (IQR) | |||||
| Length of ICU stay (d) | 5 (2-9) | 3 (2-8) | 5 (2-10) | 5 (2-10) | .83 |
| Length of hospital stay (d) | 20 (8-33) | 21 (9-45) | 24 (11-49) | 23 (12-45) | .21 |
| ICU-acquired complications, n (%) | |||||
| None | 51 (83.6%) | 105 (86.8%) | 133 (79.6%) | 476 (82.1%) | .43 |
| Acute kidney injury | 2 (3.3%) | 6 (5.0%) | 17 (10.2%) | 50 (8.6%) | .19 |
| Acute lung injury | 2 (3.3%) | 2 (1.7%) | 8 (4.8%) | 29 (5.0%) | .40 |
| Mortality, n (%) | |||||
| ICU | 29 (47.5%)*†‡ | 40 (33.1%)*† | 27 (16.2%) | 82 (14.1%) | <.001 |
| Hospital | 34 (55.7%)*† | 56 (46.3%)*† | 46 (27.5%) | 156 (26.9%) | <.001 |
| 30 d | 33 (54.1%)*†‡ | 45 (37.2%)*† | 42 (25.1%) | 132 (22.8%) | <.001 |
| 60 d | 34 (55.7%)*†‡ | 54 (44.6%)*† | 48 (28.7%) | 160 (27.6%) | <.001 |
| 90 d | 38 (62.3%)*† | 60 (49.6%)*† | 53 (31.7%) | 180 (31.0%) | <.001 |
| 1 y | 43 (70.5%)*† | 68 (56.2%)*† | 71 (42.5%) | 244 (42.1%) | <.001 |
| . | Very low (<50 × 109/L) . | Intermediate-low (50 × 109 to 99 × 109/L) . | Low (100 × 109 to 149 × 109/L) . | Normal (150 × 109 to 399 × 109/L) . | P . |
|---|---|---|---|---|---|
| Patients, n (%) | 61 (6.6%) | 121 (13.0%) | 167 (17.9%) | 580 (62.3%) | |
| Length of stay median (IQR) | |||||
| Length of ICU stay (d) | 5 (2-9) | 3 (2-8) | 5 (2-10) | 5 (2-10) | .83 |
| Length of hospital stay (d) | 20 (8-33) | 21 (9-45) | 24 (11-49) | 23 (12-45) | .21 |
| ICU-acquired complications, n (%) | |||||
| None | 51 (83.6%) | 105 (86.8%) | 133 (79.6%) | 476 (82.1%) | .43 |
| Acute kidney injury | 2 (3.3%) | 6 (5.0%) | 17 (10.2%) | 50 (8.6%) | .19 |
| Acute lung injury | 2 (3.3%) | 2 (1.7%) | 8 (4.8%) | 29 (5.0%) | .40 |
| Mortality, n (%) | |||||
| ICU | 29 (47.5%)*†‡ | 40 (33.1%)*† | 27 (16.2%) | 82 (14.1%) | <.001 |
| Hospital | 34 (55.7%)*† | 56 (46.3%)*† | 46 (27.5%) | 156 (26.9%) | <.001 |
| 30 d | 33 (54.1%)*†‡ | 45 (37.2%)*† | 42 (25.1%) | 132 (22.8%) | <.001 |
| 60 d | 34 (55.7%)*†‡ | 54 (44.6%)*† | 48 (28.7%) | 160 (27.6%) | <.001 |
| 90 d | 38 (62.3%)*† | 60 (49.6%)*† | 53 (31.7%) | 180 (31.0%) | <.001 |
| 1 y | 43 (70.5%)*† | 68 (56.2%)*† | 71 (42.5%) | 244 (42.1%) | <.001 |
Significant vs normal platelet count (150 × 109 to 399 × 109/L) using a Dunn's test of multiple comparisons using rank sums.
Significant vs low platelet count (100 × 109 to 149 × 109/L) using a Dunn's test of multiple comparisons using rank sums.
Significant vs intermediate-low platelet count (50 × 109 to 99 × 109/L) using a Dunn's test of multiple comparisons using rank sums.